Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Neuroprotection mediated through estrogen receptor-alpha in astrocytes.
HLA-DRB1*1501 tagging rs3135388 polymorphism is not associated with neuromyelitis optica.
IL-17 and Th17 Cells.
The relevance of animal models in multiple sclerosis research.
Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects.
The MS Microbiome Consortium (MSMC): an academic multi-disciplinary collaborative effort to elucidate the role of the gut microbiota in MS
Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study.
GlaxoSmithKline Protocol Summaries: Firategrast
Integrating Acupuncture Within a Wellness Intervention for Women With Multiple Sclerosis: A Feasibility Study.
Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort.
IL-2Rβγ-signaling contributes to regulatory T cell maintenance and stability in daclizumab HYP-treated RRMS patients
Teriflunomide modest help but safe for MS
Management of worsening multiple sclerosis with mitoxantrone: a review.
Setting a research agenda for progressive multiple sclerosis: The International Collaborative on Progressive MS.
FGF2 and FGFR1 signaling regulate functional recovery following cuprizone demyelination.
Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial.
Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis.
Health-related quality of life in multiple sclerosis: Direct and indirect effects of comorbidity.
Quantifying the early stages of remyelination following cuprizone-induced demyelination.
Sex differences in autoimmune diseases.
Optical coherence tomography reflects brain atrophy in MS: A four year study.
Sex differences in autoimmune disease.
In vitro and in vivo pharmacological models to assess demyelination and remyelination.
Biogen Idec reports positive top-line results from Phase 2 anti-LINGO-1 trial in people with acute optic neuritis
Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study.
Pages
« first
‹ previous
…
17
18
19
20
21
22
23
24
25
…
next ›
last »